EMEA-001094-PIP01-10-M04
Key facts
| Invented name |
Aubagio
|
| Active substance |
Teriflunomide
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0165/2017
|
| PIP number |
EMEA-001094-PIP01-10-M04
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of multiple sclerosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Genzyme Europe B.V. / Sanofi-Aventis groupe
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|